EichorEICHOR
Location: Maastricht Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Maastricht

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
NA · University Hospital Maastricht · University Hospital, Geneva · NCT06207383The DRAGON 2 Trial
NA · Maastricht University Medical Center+ · Maastricht University · NCT05428735The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms
Phase 3 · MaastrichtUMC · Maastricht University Medical Center · NCT05367089Randomization of Single vs Multiple Arterial Grafts
NA · MUMC Maastricht (University Medical Centre) · Weill Medical College of Cornell University · NCT03217006A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
Phase 4 · Maastricht UMC+ · Sint Maartenskliniek · NCT07160231A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Sele
NA · Maastricht UMC · Alimentiv Inc. · NCT07363044Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Maastricht UMC+ · Eli Lilly and Company · NCT06890598A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Maastricht UMC · Janssen Research & Development, LLC · NCT07499232Anastomotic Leakage Prevention by Endovascular Stenting of the Superior Mesenteric Artery
NA · Maastricht Universitair Medisch Centrum (MUMC+) · Medisch Spectrum Twente · NCT07486570Southeast Netherlands Advanced Metastatic Breast Cancer Registry
Phase N/A · Multiple hospitals in the Netherlands (see Eligibility) · Academisch Ziekenhuis Maastricht · NCT03577197Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients
Phase 4 · Maastricht UMC+ · University Hospital, Antwerp · NCT05701241A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Maastricht UMC+ · Pfizer · NCT0714428018F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.
Phase 2 · Maastricht University Medical Center+ · Maastricht University Medical Center · NCT06335069Study on Prognosis of Acutely Ruptured Intracranial Aneurysms
Phase N/A · Maastricht UMC · Haaglanden Medical Centre · NCT05851989[18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary Origin
NA · Maastricht UMC · Erasmus Medical Center · NCT06644716Effect of Probiotics on Appetite Regulation in Adults With Overweight/Obesity
NA · Maastricht University, Department of Nutrition and Movement · Maastricht University Medical Center · NCT07715955RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
NA · Maastricht UMC · AgNovos Healthcare, LLC · NCT04796350A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Maastricht Universitair Medisch Centrum · Amgen · NCT07005128A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-0
Phase 3 · Maastricht UMC+ ( Site 1901) · Merck Sharp & Dohme LLC · NCT07489495Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer
Phase N/A · Maastricht University Medical Center · Maastricht University Medical Center · NCT04486495Prospective Registry of Patients Undergoing Cardiac CT With NAEOTOM Alpha PCD-CT Before TAVI Procedure
Phase N/A · Maastricht University · Semmelweis University · NCT07016477Dutch-Depression Outcome Trial Comparing 5 Day Multi Daily Neuronavigated Theta Burst Sessions With 6 Weeks rTMS
NA · Maastricht UMC · Amsterdam UMC, location VUmc · NCT05900271A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Maastricht UMC+ ( Site 1705) · Merck Sharp & Dohme LLC · NCT06623422A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Maastricht Universitair Medisch Centrum /ID# 233932 · AbbVie · NCT04928846PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy
Phase 3 · Stichting Maastricht Radiation Oncology (MAASTRO) · University of Aarhus · NCT05055648External Vacuum Expansion: Evaluation in Breast Reconstructive Surgery Evaluation in Breast Reconstructive Surgery
NA · Maastricht University Medical Center+ · Maastricht University Medical Center · NCT05003635Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of
Phase 3 · Research Site · AstraZeneca · NCT06921785Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Phase 2/Phase 3 · Maastricht Universitair Medisch Centrum · Exelixis · NCT06943755Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium
Phase N/A · Maastricht University Medical Center · Maastricht University Medical Center · NCT04745195
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.